These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 29970196)
21. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression. Takada Y; Ichikawa H; Badmaev V; Aggarwal BB J Immunol; 2006 Mar; 176(5):3127-40. PubMed ID: 16493072 [TBL] [Abstract][Full Text] [Related]
22. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata. Raja AF; Ali F; Khan IA; Shawl AS; Arora DS; Shah BA; Taneja SC BMC Microbiol; 2011 Mar; 11():54. PubMed ID: 21406118 [TBL] [Abstract][Full Text] [Related]
23. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
24. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family. Takahashi M; Sung B; Shen Y; Hur K; Link A; Boland CR; Aggarwal BB; Goel A Carcinogenesis; 2012 Dec; 33(12):2441-9. PubMed ID: 22983985 [TBL] [Abstract][Full Text] [Related]
25. GPR17 signaling activation by CHBC agonist induced cell death via modulation of MAPK pathway in glioblastoma. Nguyen P; Doan P; Murugesan A; Ramesh T; Rimpilainen T; Candeias NR; Yli-Harja O; Kandhavelu M Life Sci; 2022 Feb; 291():120307. PubMed ID: 35016881 [TBL] [Abstract][Full Text] [Related]
26. The effects of cucurbitacin E on GADD45β-trigger G2/M arrest and JNK-independent pathway in brain cancer cells. Cheng AC; Hsu YC; Tsai CC J Cell Mol Med; 2019 May; 23(5):3512-3519. PubMed ID: 30912292 [TBL] [Abstract][Full Text] [Related]
27. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2. Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615 [TBL] [Abstract][Full Text] [Related]
28. Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Lu M; Xia L; Hua H; Jing Y Cancer Res; 2008 Feb; 68(4):1180-6. PubMed ID: 18281494 [TBL] [Abstract][Full Text] [Related]
29. S670, an amide derivative of 3-O-acetyl-11-keto-β-boswellic acid, induces ferroptosis in human glioblastoma cells by generating ROS and inhibiting STX17-mediated fusion of autophagosome and lysosome. Yang YH; Li W; Ren LW; Yang H; Zhang YZ; Zhang S; Hao Y; Yu DK; Tong RS; Du GH; Shi JY; Wang JH Acta Pharmacol Sin; 2024 Jan; 45(1):209-222. PubMed ID: 37749236 [TBL] [Abstract][Full Text] [Related]
30. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458 [TBL] [Abstract][Full Text] [Related]
31. The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice. Wang R; Wang Y; Gao Z; Qu X Drug Discov Ther; 2014 Feb; 8(1):25-32. PubMed ID: 24647155 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of Novel Acetyl-11-keto-β-boswellic Acid Derivatives as Potential Anti-GBM Agents. Sun M; Zhang S; Wang J; Du G; Ji T Chem Biodivers; 2024 Apr; 21(4):e202301979. PubMed ID: 38302832 [TBL] [Abstract][Full Text] [Related]
33. Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways. Yuan Y; Cui SX; Wang Y; Ke HN; Wang RQ; Lou HX; Gao ZH; Qu XJ Biochim Biophys Acta; 2013 Oct; 1830(10):4907-16. PubMed ID: 23850473 [TBL] [Abstract][Full Text] [Related]
34. Eslicarbazepine induces apoptosis and cell cycle arrest in C6 glioma cells in vitro and suppresses tumor growth in an intracranial rat model. Afsordeh N; Pournajaf S; Bayat H; Mohajerani F; Shojaei A; Mirnajafi-Zadeh J; Pourgholami MH BMC Cancer; 2024 Sep; 24(1):1099. PubMed ID: 39232721 [TBL] [Abstract][Full Text] [Related]
35. [Effect of acetyl-11-keto-β-boswellic acid on proliferation, apoptosis and cell cycle of human acute myeloid leukemia cell line HL-60]. Yuan XY; Li YH; Qi ZH; Peng MY; Wan Z; Wang GP; Chen FP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1440-4. PubMed ID: 21176347 [TBL] [Abstract][Full Text] [Related]
36. AKBA inhibits radiotherapy resistance in lung cancer by inhibiting maspin methylation and regulating the AKT/FOXO1/p21 axis. Gong C; Li W; Wu J; Li YY; Ma Y; Tang LW J Radiat Res; 2023 Jan; 64(1):33-43. PubMed ID: 36300343 [TBL] [Abstract][Full Text] [Related]
37. The major Boswellia serrata active 3-acetyl-11-keto-β-boswellic acid strengthens interleukin-1α upregulation of matrix metalloproteinase-9 via JNK MAP kinase activation. Ranzato E; Martinotti S; Volante A; Tava A; Masini MA; Burlando B Phytomedicine; 2017 Dec; 36():176-182. PubMed ID: 29157812 [TBL] [Abstract][Full Text] [Related]
38. Quantitative Determination of 3-O-Acetyl-11-Keto-βBoswellic Acid (AKBA) and Other Boswellic Acids in Boswellia sacra Flueck (syn. B. carteri Birdw) and Boswellia serrata Roxb. Mannino G; Occhipinti A; Maffei ME Molecules; 2016 Oct; 21(10):. PubMed ID: 27782055 [TBL] [Abstract][Full Text] [Related]
39. Acetyl-11-keto-beta-boswellic acid inhibits cell proliferation and growth of oral squamous cell carcinoma via RAB7B-mediated autophagy. Pan D; Wang Q; Tang S; Wu X; Cai L; Wang Z; Li Y; Huang M; Zhou Y; Shen YQ Toxicol Appl Pharmacol; 2024 Apr; 485():116906. PubMed ID: 38513840 [TBL] [Abstract][Full Text] [Related]
40. Acetyl-macrocalin B, an ent-kaurane diterpenoid, initiates apoptosis through the ROS-p38-caspase 9-dependent pathway and induces G2/M phase arrest via the Chk1/2-Cdc25C-Cdc2/cyclin B axis in non-small cell lung cancer. Wang JN; Zhang ZR; Che Y; Yuan ZY; Lu ZL; Li Y; Li N; Wan J; Sun HD; Sun N; Puno PT; He J Cancer Biol Ther; 2018 Jul; 19(7):609-621. PubMed ID: 29565730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]